Skip to main content
NVDA-2.39%AAPL+2.31%GOOGL+0.10%MSFT-0.02%AMZN+0.06%TSM-0.72%SPCX+1.69%AVGO-0.04%META+0.40%TSLA-0.45%SKHY-3.99%MU-4.17%BRK-B-0.06%LLY+0.40%JPM-0.38%AMD-2.33%WMT+0.16%V-0.25%XOM-0.26%ASMLa-1.56%JNJ-0.22%INTC-4.20%MA-0.59%0700.HK-1.94%ORCL-2.03%1398.HK+0.79%BAC-0.26%ABBV+0.52%CSCO-0.44%CVX-0.51%COST-0.10%LRCX-3.66%KO+0.59%CAT-0.99%AMAT-2.21%0005.HK-0.78%AP2d-1.57%UNH-0.63%DELL-2.88%HSBA.L-1.01%MS+0.01%PG-0.28%GE+0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.11%GS-0.18%0939.HK+1.66%NZDJPY-2.68%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.50%GBPJPY-1.39%EURJPY-1.37%CADJPY-1.36%EURNZD+1.36%NZDCAD-1.34%GBPNZD+1.31%NZDUSD-1.21%NZDCHF-1.04%USDNOK+0.91%EURNOK+0.87%CHFNOK+0.78%AUDNZD+0.75%USDZAR+0.68%USDSEK+0.68%NOKJPY-0.67%EURZAR+0.64%EURSEK+0.64%AUDDKK-0.63%AUDCAD-0.62%EURAUD+0.60%GBPAUD+0.55%GBPZAR+0.55%CHFSEK+0.54%AUDSGD-0.50%AUDUSD-0.46%USDTHB+0.45%USDMXN+0.42%GBPTRY+0.41%NZDSGD-0.32%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%AUDCHF-0.28%GBPCHF+0.27%USDPLN+0.25%AUDNOK+0.24%EURPLN+0.20%USDCHF+0.19%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.09%NZDMXN-0.08%SGDJPY+0.07%USDCNH+0.05%EURHKD-0.05%EURGBP+0.04%GBPCAD-0.04%USDCOP-0.04%EURCNH+0.04%USDDKK+0.03%GBPSGD+0.03%CHFSGD+0.03%USDHKD+0.01%PLNJPY-0.01%EURDKK-0.01%EURCAD0.00%XPTUSD-4.74%HG1-4.47%GAGUSD-4.15%XAGUSD-4.14%UKOIL+3.54%USOIL+3.11%SUGAR+1.50%XAUUSD-0.98%GAUUSD-0.98%COFFEE-0.76%COTTON+0.66%S1+0.65%BTCUSD-1.21%ETHUSD-1.02%USDTUSD-0.02%XRPUSD-2.60%SOLUSD-1.48%TRXUSDT0.00%ZECUSDT-5.54%DOGEUSD-2.81%XMRUSDT-1.66%LINKUSD-1.09%XLMUSD-1.92%BCHUSDT-10.38%LTCUSD-1.72%UNIUSD-3.29%TONUSD+24.88%HBARUSDT-1.85%SUIUSD-3.41%TAOUSDT-5.10%AAVEUSD-2.76%DOTUSDT-3.34%ICPUSDT-0.79%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.35%ARBUSDT+1.64%JUPUSDT-2.96%INJUSDT-4.80%STXUSDT-3.07%FETUSDT-3.57%TIAUSDT-0.87%PYTHUSDT+0.14%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.40%OPUSDT-3.00%IOTAUSDT-3.76%POLUSDT-5.71%AXSUSDT-2.47%FARTCOINUSDT-2.75%EOSUSDT-0.93%DYDXUSDT-0.80%ORDIUSDT-0.83%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.39%AAPL+2.31%GOOGL+0.10%MSFT-0.02%AMZN+0.06%TSM-0.72%SPCX+1.69%AVGO-0.04%META+0.40%TSLA-0.45%SKHY-3.99%MU-4.17%BRK-B-0.06%LLY+0.40%JPM-0.38%AMD-2.33%WMT+0.16%V-0.25%XOM-0.26%ASMLa-1.56%JNJ-0.22%INTC-4.20%MA-0.59%0700.HK-1.94%ORCL-2.03%1398.HK+0.79%BAC-0.26%ABBV+0.52%CSCO-0.44%CVX-0.51%COST-0.10%LRCX-3.66%KO+0.59%CAT-0.99%AMAT-2.21%0005.HK-0.78%AP2d-1.57%UNH-0.63%DELL-2.88%HSBA.L-1.01%MS+0.01%PG-0.28%GE+0.11%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.34%HD-1.11%GS-0.18%0939.HK+1.66%NZDJPY-2.68%AUDJPY-1.96%CHFJPY-1.68%USDJPY-1.50%GBPJPY-1.39%EURJPY-1.37%CADJPY-1.36%EURNZD+1.36%NZDCAD-1.34%GBPNZD+1.31%NZDUSD-1.21%NZDCHF-1.04%USDNOK+0.91%EURNOK+0.87%CHFNOK+0.78%AUDNZD+0.75%USDZAR+0.68%USDSEK+0.68%NOKJPY-0.67%EURZAR+0.64%EURSEK+0.64%AUDDKK-0.63%AUDCAD-0.62%EURAUD+0.60%GBPAUD+0.55%GBPZAR+0.55%CHFSEK+0.54%AUDSGD-0.50%AUDUSD-0.46%USDTHB+0.45%USDMXN+0.42%GBPTRY+0.41%NZDSGD-0.32%GBPHKD+0.32%EURCHF+0.31%CADCHF+0.30%GBPMXN-0.28%AUDCHF-0.28%GBPCHF+0.27%USDPLN+0.25%AUDNOK+0.24%EURPLN+0.20%USDCHF+0.19%USDILS+0.16%USDSGD+0.16%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%GBPUSD+0.11%USDTRY+0.11%EURCZK-0.09%NZDMXN-0.08%SGDJPY+0.07%USDCNH+0.05%EURHKD-0.05%EURGBP+0.04%GBPCAD-0.04%USDCOP-0.04%EURCNH+0.04%USDDKK+0.03%GBPSGD+0.03%CHFSGD+0.03%USDHKD+0.01%PLNJPY-0.01%EURDKK-0.01%EURCAD0.00%XPTUSD-4.74%HG1-4.47%GAGUSD-4.15%XAGUSD-4.14%UKOIL+3.54%USOIL+3.11%SUGAR+1.50%XAUUSD-0.98%GAUUSD-0.98%COFFEE-0.76%COTTON+0.66%S1+0.65%BTCUSD-1.21%ETHUSD-1.02%USDTUSD-0.02%XRPUSD-2.60%SOLUSD-1.48%TRXUSDT0.00%ZECUSDT-5.54%DOGEUSD-2.81%XMRUSDT-1.66%LINKUSD-1.09%XLMUSD-1.92%BCHUSDT-10.38%LTCUSD-1.72%UNIUSD-3.29%TONUSD+24.88%HBARUSDT-1.85%SUIUSD-3.41%TAOUSDT-5.10%AAVEUSD-2.76%DOTUSDT-3.34%ICPUSDT-0.79%ONDOUSDT-2.76%WLDUSDT-2.43%ATOMUSDT-3.35%ARBUSDT+1.64%JUPUSDT-2.96%INJUSDT-4.80%STXUSDT-3.07%FETUSDT-3.57%TIAUSDT-0.87%PYTHUSDT+0.14%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.40%OPUSDT-3.00%IOTAUSDT-3.76%POLUSDT-5.71%AXSUSDT-2.47%FARTCOINUSDT-2.75%EOSUSDT-0.93%DYDXUSDT-0.80%ORDIUSDT-0.83%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
RE

Replimune Group, Inc. (REPL)

NASDAQ • Healthcare

$14.45
-$0.32 (-2.2%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$14.54
Previous Close$14.45
Day Range$14.3 - $14.76
Avg. Volume (3M)2.6M
Market Cap$1.2B
52 Week Range
$1.5$16.33
Next EarningsIn 56 daysNov 5, 2026

Metrics Over Time

Fundamentals & Financials

Revenue (TTM)
$0
Net Income (TTM)
-$297M
EPS (TTM)
-$3.15
ROA (TTM)
-117.65%
Current Ratio
5.23

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-0.2%Q1 2026-$0.77
-4.1%Q2 2026-$0.76
-3.7%Q3 2026-$0.72
Next

Nov 5

in 56 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Replimune Group, Inc.

Replimune Group, Inc. is a clinical-stage biotechnology company listed on NASDAQ as REPL that develops oncolytic immuno-gene therapies for cancer. The company uses a proprietary Immunotherapy platform to engineer therapeutic candidates designed to activate the body's immune system against malignant cells, and it operates from Woburn, Massachusetts.

Name
Replimune Group, Inc.
CEO
Sushil Patel
Website
www.replimune.com
Industry
Healthcare
Year Founded
2015
Employees
465

Today's Snapshot

AI-generated

The session opened with REPL slightly higher at 14.47, while its sector was flat. Shareholders brought a class action against Replimune over alleged nondisclosure.

Trading Volume

Below 10d avg (1.5M)

651.3K

vs S&P 500 Today

Strong Underperformance

-3.31%

Updated: September 10, 2026 at 14:46 UTC

Technical Indicators

3 Buy3 Neutral2 Sell
REPL shows a cautiously bullish profile driven chiefly by a solid ADX reading that signals a defined trend while shorter-term momentum indicators look mixed and slightly negative. Price sits below near-term moving averages but remains above most medium- and long-term averages, suggesting recent weakness inside a broader up structure, and volatility is elevated which has kept intraday moves wide. Volume metrics are soft, indicating limited buying conviction even as oscillators hold near neutral. Technical takeaway: trend strength supports a modest buy stance despite short-term momentum and higher volatility.
All signals
  • EMA (5 indicators)$9.42 - $14.88
    Buy
  • RSI (14)49.94
    Neutral
  • Stochastic %K (14, 3, 3)25.40
    Neutral
  • MACD Level (12, 26)0.67
    Neutral

Peers & Related Assets

IOVAIovance Biotherapeutics, Inc.
$8.43-3.1%
MBXMBX Biosciences, Inc. Common Stock
$62.91-0.1%
VIRVir Biotechnology, Inc.
$10.81-3.3%
AVBPArriVent BioPharma, Inc.
$29.79-1.6%
MGTXMeiraGTx Holdings plc
$13.26-2.0%
PRMEPrime Medicine, Inc.
$3.47-2.5%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.